Takeda Pharmaceutical Company Limited (TKPHF)
OTCMKTS · Delayed Price · Currency is USD
27.17
-1.83 (-6.30%)
Oct 9, 2025, 9:43 AM EDT
TKPHF Market Cap
TKPHF has a market cap or net worth of $44.22 billion as of October 9, 2025. Its market cap has decreased by -5.93% in one year.
Market Cap
44.22B
Enterprise Value
74.85B
Revenue
31.05B
Ranking
n/a
PE Ratio
46.59
Stock Price
$27.17
Market Cap Chart
Since January 14, 1992, TKPHF's market cap has increased from 8.47B to 44.22B, an increase of 421.96%. That is a compound annual growth rate of 5.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 44.58B | 5.71% |
| Dec 30, 2024 | 42.17B | -6.54% |
| Dec 29, 2023 | 45.12B | -6.90% |
| Dec 30, 2022 | 48.46B | 14.20% |
| Dec 30, 2021 | 42.44B | -25.32% |
| Dec 30, 2020 | 56.83B | -8.34% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 674.12M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 380.49M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 321.63M |
| American Oncology Network | 273.17M |
| Silence Therapeutics | 245.14M |